Harvard Bioscience (HBIO)

$5.41 -1.43 (-20.91%)
Market Cap 30.85M
Revenue (ttm) 86.55M
Net Income (ttm) -56.70M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -65.51%
Debt to Equity Ratio 2.61
Volume 53,100
Avg Vol 59,493
Day's Range N/A - N/A
Shares Out 4.51M
Stochastic %K 0%
Beta 1.57
Analysts Sell
Price Target $60.00

Company Profile

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific me...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 508 893 8999
Fax: 508 429 5732
Address:
84 October Hill Road, Suite 10, Holliston, United States
Axen7
Axen7 May. 12 at 6:19 PM
$HBIO glad sold when I did. Was not a fan of this earnings. Increased debt was not what I wanted. It was a classic pump into earnings followed by a sell off. GL here though bulls
0 · Reply
SuperGreenToday
SuperGreenToday May. 12 at 12:38 PM
$HBIO Share Price: $6.89 Contract Selected: Aug 21, 2026 $4.0 Calls Buy Zone: $0.04 – $0.05 Target Zone: $0.07 – $0.08 Potential Upside: 67% ROI Time to Expiration: 100 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
EarningsInsider
EarningsInsider May. 12 at 12:31 PM
https://www.marketbeat.com/earnings/reports/2026-5-12-harvard-bioscience-inc-stock/ $HBIO Harvard Bioscience Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 12 at 11:36 AM
$HBIO Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.08 up 99.30% YoY • Reported revenue of $20.75M down -4.68% YoY • Harvard Bioscience reaffirms full-year 2026 guidance, anticipating revenue growth of 2% to 4%, adjusted gross margin of 58% to 60%, and adjusted EBITDA growth of 6% to 10%.
0 · Reply
Axen7
Axen7 May. 6 at 5:30 PM
$HBIO I am outtie all. Taking my profits finally. The low volume and uptrend is kind of reminding me of another stock I didn’t sell, for it to just get halved by an offering by the company in seconds. Gl to all here and crush it.
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 28 at 2:24 PM
$HBIO RSI: 60.36, MACD: 0.4121 Vol: 0.83, MA20: 5.80, MA50: 5.57 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Axen7
Axen7 Apr. 21 at 4:01 PM
$HBIO stop do the go down. Do the go up!
0 · Reply
Don_Frye
Don_Frye Apr. 20 at 7:10 PM
$NKTR $OTLK $HBIO $BYND what a day
0 · Reply
GTMStox
GTMStox Apr. 20 at 2:37 PM
$HBIO Looks like we got some volume coming in today
0 · Reply
Axen7
Axen7 Apr. 17 at 3:01 PM
$HBIO do the thing and don’t stops! Release some banger news for us one time!
0 · Reply
Latest News on HBIO
Harvard Bioscience reports Q1 adjusted EPS (33c) vs. ($1.25) last year

2026-05-12T14:05:54.000Z - 22 hours ago

Harvard Bioscience reports Q1 adjusted EPS (33c) vs. ($1.25) last year

Harvard Bioscience reiterates Q2 revenue view $20.5M-$22.5M

2026-05-12T13:59:42.000Z - 22 hours ago

Harvard Bioscience reiterates Q2 revenue view $20.5M-$22.5M

Harvard Bioscience reaffirms FY26 revenue growth of 2%-4%

2026-05-12T13:45:49.000Z - 22 hours ago

Harvard Bioscience reaffirms FY26 revenue growth of 2%-4%

Harvard Bioscience Earnings Call Transcript: Q1 2026

May 12, 2026, 8:00 AM EDT - 1 day ago

Harvard Bioscience Earnings Call Transcript: Q1 2026

Harvard Bioscience Announces First Quarter 2026 Financial Results

May 12, 2026, 7:30 AM EDT - 1 day ago

Harvard Bioscience Announces First Quarter 2026 Financial Results

Harvard Bioscience to Participate in Upcoming Investor Conferences

May 7, 2026, 7:30 AM EDT - 6 days ago

Harvard Bioscience to Participate in Upcoming Investor Conferences

Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET

Apr 28, 2026, 7:30 AM EDT - 15 days ago

Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET

Harvard Bioscience Transcript: 2026 KeyBanc Capital Markets Healthcare Forum

Mar 17, 2026, 2:15 PM EDT - 2 months ago

Harvard Bioscience Transcript: 2026 KeyBanc Capital Markets Healthcare Forum

Harvard Bioscience price target adjusted to $6 at Benchmark after reverse split

2026-03-16T12:15:35.000Z - 2 months ago

Harvard Bioscience price target adjusted to $6 at Benchmark after reverse split

Harvard Bioscience trading halted, news pending

2026-03-13T23:56:02.000Z - 2 months ago

Harvard Bioscience trading halted, news pending

Harvard Bioscience price target lowered to 60c from $2 at Benchmark

2026-03-13T11:32:32.000Z - 2 months ago

Harvard Bioscience price target lowered to 60c from $2 at Benchmark

Harvard Bioscience Earnings Call Transcript: Q4 2025

Mar 12, 2026, 8:00 AM EDT - 2 months ago

Harvard Bioscience Earnings Call Transcript: Q4 2025

Harvard Bioscience reports Q4 adjusted EPS (0c) vs 6c last year

2026-03-12T11:41:52.000Z - 2 months ago

Harvard Bioscience reports Q4 adjusted EPS (0c) vs 6c last year

Harvard Bioscience appoints interim CFO Mark Frost as CFO

2026-03-12T11:41:33.000Z - 2 months ago

Harvard Bioscience appoints interim CFO Mark Frost as CFO

Harvard Bioscience sees Q1 revenue $20M-$22M

2026-03-12T11:41:25.000Z - 2 months ago

Harvard Bioscience sees Q1 revenue $20M-$22M

Harvard Bioscience sees FY26 revenue growth 2%-4%

2026-03-12T11:40:54.000Z - 2 months ago

Harvard Bioscience sees FY26 revenue growth 2%-4%

Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results

Mar 12, 2026, 7:30 AM EDT - 2 months ago

Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results

Harvard Bioscience announces 1-for-10 reverse stock split

2026-03-06T21:05:29.000Z - 2 months ago

Harvard Bioscience announces 1-for-10 reverse stock split

Harvard Bioscience Announces Reverse Stock Split

Mar 6, 2026, 4:01 PM EST - 2 months ago

Harvard Bioscience Announces Reverse Stock Split

Harvard Bioscience Transcript: EGM 2026

Mar 6, 2026, 10:00 AM EST - 2 months ago

Harvard Bioscience Transcript: EGM 2026

Harvard Bioscience to Participate in KeyBanc's Virtual Healthcare Forum

Mar 3, 2026, 7:30 AM EST - 2 months ago

Harvard Bioscience to Participate in KeyBanc's Virtual Healthcare Forum

Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET

Feb 26, 2026, 7:30 AM EST - 2 months ago

Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET

Harvard Bioscience outlines strategy for growth

2026-02-10T12:41:11.000Z - 3 months ago

Harvard Bioscience outlines strategy for growth

Harvard Bioscience reports preliminary Q4 revenue $23.7M

2026-02-10T12:35:19.000Z - 3 months ago

Harvard Bioscience reports preliminary Q4 revenue $23.7M

Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas

Feb 10, 2026, 7:30 AM EST - 3 months ago

Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas

Harvard Bioscience files to sell 9.5M shares of common stock for holders

2026-01-30T22:05:24.000Z - 3 months ago

Harvard Bioscience files to sell 9.5M shares of common stock for holders

Harvard Bioscience closes manufacturing operations in Massachusetts

2026-01-29T21:50:18.000Z - 3 months ago

Harvard Bioscience closes manufacturing operations in Massachusetts

Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth

Jan 29, 2026, 4:30 PM EST - 3 months ago

Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth

Harvard Bioscience enters agreement with BroadOak Capital Partners

2025-12-17T12:40:47.000Z - 5 months ago

Harvard Bioscience enters agreement with BroadOak Capital Partners

Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package

Dec 17, 2025, 7:30 AM EST - 5 months ago

Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package

Harvard Bioscience Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:00 AM EST - 6 months ago

Harvard Bioscience Earnings Call Transcript: Q3 2025

Harvard Bioscience sees Q4 revenue $22.5M-$24.5M

2025-11-06T12:13:13.000Z - 6 months ago

Harvard Bioscience sees Q4 revenue $22.5M-$24.5M

Harvard Bioscience reports Q3 adjusted EPS 0c vs. (2c) last year

2025-11-06T12:05:22.000Z - 6 months ago

Harvard Bioscience reports Q3 adjusted EPS 0c vs. (2c) last year

Harvard Bioscience Announces Third Quarter 2025 Financial Results

Nov 6, 2025, 7:00 AM EST - 6 months ago

Harvard Bioscience Announces Third Quarter 2025 Financial Results

Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET

Oct 30, 2025, 8:00 AM EDT - 6 months ago

Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET

Harvard Bioscience expands distribution agreement with Fisher Scientific

2025-09-16T11:05:08.000Z - 8 months ago

Harvard Bioscience expands distribution agreement with Fisher Scientific

TMO

Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States

Sep 16, 2025, 7:00 AM EDT - 8 months ago

Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States

Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors

Sep 9, 2025, 7:00 AM EDT - 8 months ago

Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors

Harvard Bioscience Earnings Call Transcript: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 9 months ago

Harvard Bioscience Earnings Call Transcript: Q2 2025

Harvard Bioscience Announces Second Quarter 2025 Financial Results

Aug 11, 2025, 7:00 AM EDT - 9 months ago

Harvard Bioscience Announces Second Quarter 2025 Financial Results

Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET

Aug 4, 2025, 4:30 PM EDT - 10 months ago

Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET

Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board

Jul 17, 2025, 7:00 AM EDT - 10 months ago

Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board

Harvard Bioscience Appoints John Duke to Board of Directors

Jun 2, 2025, 4:57 PM EDT - 1 year ago

Harvard Bioscience Appoints John Duke to Board of Directors

Harvard Bioscience Earnings Call Transcript: Q1 2025

May 12, 2025, 8:00 AM EDT - 1 year ago

Harvard Bioscience Earnings Call Transcript: Q1 2025

Harvard Bioscience Announces First Quarter 2025 Financial Results

May 12, 2025, 7:00 AM EDT - 1 year ago

Harvard Bioscience Announces First Quarter 2025 Financial Results

Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET

May 5, 2025, 4:45 PM EDT - 1 year ago

Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET

Harvard Bioscience Announces CFO Transition

Apr 10, 2025, 4:45 PM EDT - 1 year ago

Harvard Bioscience Announces CFO Transition

Harvard Bioscience Transcript: KeyBanc Annual Healthcare Forum 2025

Mar 19, 2025, 3:45 PM EDT - 1 year ago

Harvard Bioscience Transcript: KeyBanc Annual Healthcare Forum 2025

Harvard Bioscience Transcript: 37th Annual ROTH Conference

Mar 17, 2025, 1:00 PM EDT - 1 year ago

Harvard Bioscience Transcript: 37th Annual ROTH Conference

Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025

Mar 12, 2025, 4:00 PM EDT - 1 year ago

Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025

Harvard Bioscience Earnings Call Transcript: Q4 2024

Mar 12, 2025, 8:00 AM EDT - 1 year ago

Harvard Bioscience Earnings Call Transcript: Q4 2024

Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results

Mar 12, 2025, 7:21 AM EDT - 1 year ago

Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting

Feb 24, 2025, 4:45 PM EST - 1 year ago

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting

Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET

Feb 24, 2025, 11:00 AM EST - 1 year ago

Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET

Harvard Bioscience Transcript: Sidoti Micro-Cap Virtual Conference

Jan 22, 2025, 10:00 AM EST - 1 year ago

Harvard Bioscience Transcript: Sidoti Micro-Cap Virtual Conference

Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference

Jan 13, 2025, 5:52 PM EST - 1 year ago

Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference

Harvard Bioscience Earnings Call Transcript: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Harvard Bioscience Earnings Call Transcript: Q3 2024

Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET

Oct 29, 2024, 5:00 PM EDT - 1 year ago

Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET

Harvard Bioscience Transcript: Sidoti September Small-Cap Virtual Conference

Sep 18, 2024, 9:15 AM EDT - 1 year ago

Harvard Bioscience Transcript: Sidoti September Small-Cap Virtual Conference

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting

Sep 18, 2024, 7:30 AM EDT - 1 year ago

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting

Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference

Sep 5, 2024, 4:05 PM EDT - 1 year ago

Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference

Harvard Bioscience Earnings Call Transcript: Q2 2024

Aug 8, 2024, 10:00 AM EDT - 1 year ago

Harvard Bioscience Earnings Call Transcript: Q2 2024

Harvard Bioscience Announces Second Quarter 2024 Financial Results

Aug 8, 2024, 8:30 AM EDT - 1 year ago

Harvard Bioscience Announces Second Quarter 2024 Financial Results

Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET

Aug 2, 2024, 8:00 AM EDT - 1 year ago

Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET

Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024

Jun 6, 2024, 4:05 PM EDT - 2 years ago

Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024

Harvard Bioscience Transcript: Jefferies Global Healthcare Conference

Jun 5, 2024, 2:00 PM EDT - 2 years ago

Harvard Bioscience Transcript: Jefferies Global Healthcare Conference

Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024

May 23, 2024, 4:05 PM EDT - 2 years ago

Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024

Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference

May 16, 2024, 4:05 PM EDT - 2 years ago

Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference

Harvard Bioscience Earnings Call Transcript: Q1 2024

May 7, 2024, 8:00 AM EDT - 2 years ago

Harvard Bioscience Earnings Call Transcript: Q1 2024

Harvard Bioscience Announces First Quarter 2024 Financial Results

May 7, 2024, 7:00 AM EDT - 2 years ago

Harvard Bioscience Announces First Quarter 2024 Financial Results

Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET

Apr 29, 2024, 8:45 AM EDT - 2 years ago

Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET

Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth

Apr 9, 2024, 9:00 AM EDT - 2 years ago

Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth

Harvard Bioscience Transcript: KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Mar 19, 2024, 9:45 AM EDT - 2 years ago

Harvard Bioscience Transcript: KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti's Small Cap Conference and KeyBanc's Life Sciences & MedTech Conference

Mar 11, 2024, 8:00 AM EDT - 2 years ago

Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti's Small Cap Conference and KeyBanc's Life Sciences & MedTech Conference

Harvard Bioscience Earnings Call Transcript: Q4 2023

Mar 7, 2024, 8:00 AM EST - 2 years ago

Harvard Bioscience Earnings Call Transcript: Q4 2023

Harvard Bioscience Announces Fourth Quarter 2023 Financial Results

Mar 7, 2024, 7:00 AM EST - 2 years ago

Harvard Bioscience Announces Fourth Quarter 2023 Financial Results

Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET

Feb 27, 2024, 5:10 PM EST - 2 years ago

Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET

Harvard Bioscience to Present at Benchmark Company's Discovery One-On-One Investor Conference on December 7, 2023

Nov 20, 2023, 4:40 PM EST - 2 years ago

Harvard Bioscience to Present at Benchmark Company's Discovery One-On-One Investor Conference on December 7, 2023

Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023

Nov 9, 2023, 4:30 PM EST - 2 years ago

Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023

Harvard Bioscience Earnings Call Transcript: Q3 2023

Nov 7, 2023, 8:00 AM EST - 2 years ago

Harvard Bioscience Earnings Call Transcript: Q3 2023

Harvard Bioscience Announces Third Quarter 2023 Financial Results

Nov 7, 2023, 7:00 AM EST - 2 years ago

Harvard Bioscience Announces Third Quarter 2023 Financial Results

Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023

Nov 6, 2023, 4:30 PM EST - 2 years ago

Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023

Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET

Oct 30, 2023, 9:00 AM EDT - 2 years ago

Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET

Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research

Sep 18, 2023, 8:57 AM EDT - 2 years ago

Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research

Harvard Bioscience Earnings Call Transcript: Q2 2023

Aug 8, 2023, 8:00 AM EDT - 3 years ago

Harvard Bioscience Earnings Call Transcript: Q2 2023

Harvard Bioscience Announces Second Quarter 2023 Financial Results

Aug 8, 2023, 7:18 AM EDT - 3 years ago

Harvard Bioscience Announces Second Quarter 2023 Financial Results

Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023

Aug 3, 2023, 6:30 PM EDT - 3 years ago

Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023

Harvard Bioscience Schedules Second Quarter 2023 Earnings Conference Call for August 8, 2023 at 8:00 AM ET

Jul 27, 2023, 6:36 PM EDT - 3 years ago

Harvard Bioscience Schedules Second Quarter 2023 Earnings Conference Call for August 8, 2023 at 8:00 AM ET

Harvard Bioscience Set to Join Russell 2000® and 3000® Indexes

Jun 22, 2023, 7:55 AM EDT - 3 years ago

Harvard Bioscience Set to Join Russell 2000® and 3000® Indexes

Axen7
Axen7 May. 12 at 6:19 PM
$HBIO glad sold when I did. Was not a fan of this earnings. Increased debt was not what I wanted. It was a classic pump into earnings followed by a sell off. GL here though bulls
0 · Reply
SuperGreenToday
SuperGreenToday May. 12 at 12:38 PM
$HBIO Share Price: $6.89 Contract Selected: Aug 21, 2026 $4.0 Calls Buy Zone: $0.04 – $0.05 Target Zone: $0.07 – $0.08 Potential Upside: 67% ROI Time to Expiration: 100 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
EarningsInsider
EarningsInsider May. 12 at 12:31 PM
https://www.marketbeat.com/earnings/reports/2026-5-12-harvard-bioscience-inc-stock/ $HBIO Harvard Bioscience Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 12 at 11:36 AM
$HBIO Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.08 up 99.30% YoY • Reported revenue of $20.75M down -4.68% YoY • Harvard Bioscience reaffirms full-year 2026 guidance, anticipating revenue growth of 2% to 4%, adjusted gross margin of 58% to 60%, and adjusted EBITDA growth of 6% to 10%.
0 · Reply
Axen7
Axen7 May. 6 at 5:30 PM
$HBIO I am outtie all. Taking my profits finally. The low volume and uptrend is kind of reminding me of another stock I didn’t sell, for it to just get halved by an offering by the company in seconds. Gl to all here and crush it.
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 28 at 2:24 PM
$HBIO RSI: 60.36, MACD: 0.4121 Vol: 0.83, MA20: 5.80, MA50: 5.57 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Axen7
Axen7 Apr. 21 at 4:01 PM
$HBIO stop do the go down. Do the go up!
0 · Reply
Don_Frye
Don_Frye Apr. 20 at 7:10 PM
$NKTR $OTLK $HBIO $BYND what a day
0 · Reply
GTMStox
GTMStox Apr. 20 at 2:37 PM
$HBIO Looks like we got some volume coming in today
0 · Reply
Axen7
Axen7 Apr. 17 at 3:01 PM
$HBIO do the thing and don’t stops! Release some banger news for us one time!
0 · Reply
WestVirginian
WestVirginian Apr. 15 at 10:26 PM
$HBIO it moves with such little volume. Just waiting it out
0 · Reply
Axen7
Axen7 Apr. 13 at 4:53 PM
$HBIO do the thing now! Bang to 10 dollars you won’t 🫡
0 · Reply
BigggD
BigggD Apr. 10 at 6:56 PM
$HBIO buy the fear
0 · Reply
GTMStox
GTMStox Apr. 10 at 6:52 PM
$HBIO After all that insider buying...this is what we get. Nonsense. Added.
0 · Reply
Axen7
Axen7 Apr. 10 at 3:38 PM
$HBIO oof… 😥
0 · Reply
Axen7
Axen7 Apr. 10 at 1:50 PM
$HBIO lmao someone dumped on low volume into market and got SLAUGHTERED by the bid/ask. And now it’s been bought back up. If you had a buy set at 4.5 thank them for their donations
0 · Reply
Axen7
Axen7 Apr. 6 at 4:16 PM
$HBIO
0 · Reply
GTMStox
GTMStox Apr. 2 at 3:51 PM
$HBIO How is this going un-noticed??!!
1 · Reply
Axen7
Axen7 Apr. 2 at 3:00 PM
$HBIO one day!!
0 · Reply
PaidPiper
PaidPiper Mar. 27 at 1:37 AM
$HBIO Adaptimmune filed a 'change of address' wednesday. Right next door to Immunocore. Deal coming soon. This isn't spam, you won't hear from me again. Godspeed.
1 · Reply
InTheMoney_
InTheMoney_ Mar. 23 at 6:47 PM
$SPY $QQQ $LLY —> $HBIO low market cap, low watchers, and insiders cluster buying http://finshort.com/insiders
0 · Reply
mirage282828
mirage282828 Mar. 20 at 9:55 AM
$HBIO so my May 15th calls they're still the same are they going to get adjusted or not does anybody have any information
1 · Reply